A clinical trial at the National Institutes of Health is now doing exactly that in an attempt to cure sickle cell anemia ... pain to get narcotics, being labeled a "drug-seeker." ...

That approval comes with a black box warning on the label given the occurrence of ... coined the term “sickle cell anemia” in 1922. Herrick’s patient was identified only decades later ...

its competing sickle cell treatment also approved on Friday, at $2.2 million. Not only is Lyfgenia significantly more expensive, but its prescribing label carries a “black box” safety warning ...

Sickle cell disease ... anemia. The case was found to have an alpha thalassemia trait, and this problem is now listed in the “Limitations of Use” section of Lyfgenia’s label.

The Food and Drug Administration on Friday approved a powerful treatment for sickle cell disease ... warning — the strongest safety warning label— to Bluebird Bio’s Lyfgenia, noting that ...

Sickle cell disease affects around 100,000 people in the US, most commonly African Americans. It leads to anemia, vaso-occlusive events and crises (painful episodes in which small blockages starve ...

A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit ...

At age 45, Dr. Lakiea Bailey said, she was the oldest person with sickle cell anemia that she knew. The executive director of the nonprofit patient advocacy group the Sickle Cell Consortium was ...

Exagamglogene autotemcel (exa-cel) is a nonviral cell therapy designed to reactivate fetal hemoglobin synthesis by means of ex vivo clustered regularly interspaced short palindromic repeats ...